HBC.OL实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 22:25):

Stats
今日成交量	34 575.00
平均成交量	249 490
市值	813.87M
EPS	NOK-0.0955 ( 2023-03-31 )
下一个收益日期	( NOK0 ) 2024-05-10
Last Dividend	NOK0 ( N/A )
Next Dividend	NOK0 ( N/A )
P/E	-7.63
ATR14	NOK0.0350 (1.69%)

Hofseth BioCare ASA 相关性

10 最正相关

10 最负相关
SSG.OL	-0.816

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Hofseth BioCare ASA 财务报表

Annual	2023
营收:	NOK190.82M
毛利润:	NOK-54.56M (-28.59 %)
EPS:	NOK-0.270

FY	2023
营收:	NOK190.82M
毛利润:	NOK-54.56M (-28.59 %)
EPS:	NOK-0.270

FY	2022
营收:	NOK120.45M
毛利润:	NOK28.51M (23.67 %)
EPS:	NOK-0.370

Financial Reports:

No articles found.

Hofseth BioCare ASA

Hofseth BioCare ASA engages in providing value added biomarine ingredients for human and animal applications in Norway and internationally. Its products include Brilliant salmon oil; OmeGo salmon oil for the maintenance of healthy cholesterol and cardiovascular function; ProGo, a salmon protein hydrolysate powder used as a fast absorbing protein supplement; CalGo, a marine calcium powder produced to support cartilage function and joint health; CollaGo, a collagen peptide powder to enhance the beauty of hair, skin, and nails; and PetGo, a non-soluble protein. The company distributes its products through distributors, agents, and its own sales force. It has a research agreement with Stanford University School of Medicine for pre-clinical and clinical research on necrotizing enterocolitis and irritable bowel syndrome. The company was founded in 2000 and is headquartered in Ålesund, Norway.